MYRIAD GENETICS, INC. Interest Expense
MYRIAD GENETICS, INC. (MYGN) reported Interest Expense of $500.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- MYRIAD GENETICS, INC. interest expense for the quarter ending 2024-03-31 was $500.00K, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. interest expense for the quarter ending 2023-12-31 was $900.00K, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. interest expense for the quarter ending 2023-09-30 was $1.00M, a 25.00% increase year-over-year.
- MYRIAD GENETICS, INC. interest expense for the quarter ending 2023-06-30 was $500.00K, a 16.67% decline year-over-year.
- MYRIAD GENETICS, INC. interest expense for fiscal 2023 was $2.90M, a 9.38% decline from fiscal 2022.
- MYRIAD GENETICS, INC. interest expense for fiscal 2022 was $3.20M, a 51.52% decline from fiscal 2021.
- MYRIAD GENETICS, INC. interest expense for fiscal 2021 was $6.60M, a 41.07% decline from fiscal 2020.
- MYRIAD GENETICS, INC. interest expense for fiscal 2020 was $11.20M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $500.00K 10-Q · filed 2024-05-08 | $1.40M derived: sum of 2 quarters · filed 2024-05-08 | $2.40M derived: sum of 3 quarters · filed 2024-05-08 | $2.90M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.90M derived: sum of 2 quarters · filed 2024-02-28 | $2.40M derived: sum of 3 quarters · filed 2024-02-28 | $2.90M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $1.00M 10-Q · filed 2023-11-07 | $1.50M derived: sum of 2 quarters · filed 2023-11-07 | $2.00M 10-Q · filed 2023-11-07 | $2.90M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-06-30 | $500.00K 10-Q · filed 2023-08-04 | $1.00M 10-Q · filed 2023-08-04 | $1.90M derived: sum of 3 quarters · filed 2024-05-08 | $2.70M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-08 | $1.40M derived: sum of 2 quarters · filed 2024-05-08 | $2.20M derived: sum of 3 quarters · filed 2024-05-08 | $2.80M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.70M derived: sum of 2 quarters · filed 2024-02-28 | $2.30M derived: sum of 3 quarters · filed 2024-02-28 | $3.20M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $800.00K 10-Q · filed 2023-11-07 | $1.40M derived: sum of 2 quarters · filed 2023-11-07 | $2.30M 10-Q · filed 2023-11-07 | $2.80M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $600.00K 10-Q · filed 2023-08-04 | $1.50M 10-Q · filed 2023-08-04 | $2.00M derived: sum of 3 quarters · filed 2024-02-28 | $3.10M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $900.00K 10-Q · filed 2023-05-04 | $1.40M derived: sum of 2 quarters · filed 2024-02-28 | $2.50M derived: sum of 3 quarters · filed 2024-02-28 | $4.50M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.60M derived: sum of 2 quarters · filed 2024-02-28 | $3.60M derived: sum of 3 quarters · filed 2024-02-28 | $6.60M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $1.10M 10-Q · filed 2022-11-02 | $3.10M derived: sum of 2 quarters · filed 2022-11-02 | $6.10M 10-Q · filed 2022-11-02 | $9.00M derived: sum of 4 quarters · filed 2022-11-02 | |
| 2021-06-30 | $2.00M 10-Q · filed 2022-08-05 | $5.00M 10-Q · filed 2022-08-05 | $7.90M derived: sum of 3 quarters · filed 2022-08-05 | $10.80M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-06 | $5.90M derived: sum of 2 quarters · filed 2022-05-06 | $8.80M derived: sum of 3 quarters · filed 2022-05-06 | $11.90M derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $2.90M 10-KT · filed 2021-03-16 | $5.80M 10-K · filed 2023-03-01 | $8.90M derived: sum of 3 quarters · filed 2021-11-04 | $11.20M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $2.90M 10-Q · filed 2021-11-04 | $6.00M derived: sum of 2 quarters · filed 2021-11-04 | $8.30M 10-Q · filed 2021-11-04 | $10.80M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $3.10M 10-Q · filed 2021-08-04 | $5.40M 10-Q · filed 2021-08-04 | $7.90M derived: sum of 3 quarters · filed 2021-08-04 | $10.80M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $2.30M 10-Q · filed 2021-05-05 | $4.80M derived: sum of 2 quarters · filed 2021-05-05 | $7.70M 10-Q · filed 2020-05-06 | $10.90M derived: sum of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | $2.50M 10-KT · filed 2021-03-16 | $5.40M 10-K · filed 2022-02-25 | $8.60M derived: sum of 3 quarters · filed 2021-03-16 | $11.80M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-09-30 | $2.90M 10-KT · filed 2021-03-16 | $6.10M derived: sum of 2 quarters · filed 2021-03-16 | $9.30M derived: sum of 3 quarters · filed 2021-03-16 | $12.70M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | $3.20M 10-KT · filed 2021-03-16 | $6.40M derived: sum of 2 quarters · filed 2021-03-16 | $9.80M derived: sum of 3 quarters · filed 2021-03-16 | $12.00M 10-K · filed 2022-02-25 | |
| 2019-03-31 | $3.20M 10-KT · filed 2021-03-16 | $6.60M derived: sum of 2 quarters · filed 2021-03-16 | $8.80M 10-Q · filed 2020-05-06 | $9.90M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $3.40M 10-KT · filed 2021-03-16 | $5.60M 10-Q · filed 2020-02-07 | $6.70M derived: sum of 3 quarters · filed 2021-03-16 | $7.20M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-09-30 | $2.20M 10-KT · filed 2021-03-16 | $3.30M derived: sum of 2 quarters · filed 2021-03-16 | $3.80M derived: sum of 3 quarters · filed 2021-03-16 | $4.50M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-06-30 | $1.10M 10-K · filed 2019-08-13 | $1.60M derived: sum of 2 quarters · filed 2019-08-13 | $2.30M derived: sum of 3 quarters · filed 2019-08-13 | $3.20M 10-KT · filed 2021-03-16 | |
| 2018-03-31 | $500.00K 10-K · filed 2019-08-13 | $1.20M derived: sum of 2 quarters · filed 2019-08-13 | $2.20M 10-Q · filed 2019-05-08 | $3.30M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2017-12-31 | $700.00K 10-K · filed 2019-08-13 | $1.60M 10-Q · filed 2019-02-06 | $1.70M 10-Q · filed 2018-02-07 | $2.80M derived: sum of 3 quarters · filed 2019-08-13 | $4.30M derived: sum of 4 quarters · filed 2019-08-13 |
| 2017-09-30 | $900.00K 10-K · filed 2019-08-13 | $2.10M derived: sum of 2 quarters · filed 2019-08-13 | $3.60M derived: sum of 3 quarters · filed 2019-08-13 | $6.20M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2017-06-30 | $1.20M 10-K · filed 2018-08-24 | $2.70M derived: sum of 2 quarters · filed 2018-08-24 | $5.30M derived: sum of 3 quarters · filed 2018-08-24 | $6.00M 10-K · filed 2019-08-13 | |
| 2017-03-31 | $1.50M 10-K · filed 2018-08-24 | $4.10M derived: sum of 2 quarters · filed 2018-08-24 | $4.80M 10-Q · filed 2018-05-09 | $4.90M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-12-31 | $2.60M 10-K · filed 2018-08-24 | $3.30M 10-Q · filed 2018-02-07 | $3.40M derived: sum of 3 quarters · filed 2018-08-24 | $3.50M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-09-30 | $700.00K 10-K · filed 2018-08-24 | $800.00K derived: sum of 2 quarters · filed 2018-08-24 | $900.00K derived: sum of 3 quarters · filed 2018-08-24 | $1.00M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-06-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $200.00K derived: sum of 2 quarters · filed 2018-08-24 | $300.00K derived: sum of 3 quarters · filed 2018-08-24 | $300.00K 10-K · filed 2018-08-24 | |
| 2016-03-31 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-03 | $200.00K derived: sum of 2 quarters · filed 2017-05-03 | $200.00K 10-Q · filed 2017-05-03 | ||
| 2015-12-31 | $100.00K 10-Q · filed 2017-02-08 | $100.00K 10-Q · filed 2017-02-08 | |||
| 2015-06-30 | $200.00K 10-K · filed 2018-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |